@ARTICLE{
author={Peric S,Narayanaswami P,Smilowski M,Slowik A,Gokhale S,Briggs C,Siddiqui U,Randhawa S,Truman M,Hickey L,Shelly S,Vu T,Vissing J},
year={2026},
title={Safety and efficacy of claseprubart, an active C1s inhibitor, in patients with generalized myasthenia gravis},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={33},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Sacca Francesco,Barnett-Tapia C,Vu T,Peric Stojan Z,Phillips Glenn A,Zhao Sihui,Gelinas D,Chiroli Silvia,Verschuuren J},
year={2022},
title={Efgartigimod improved quality-of-life in gMG: a randomised, double-blinded, placebo-controlled, phase 3 trial (ADAPT)},
journal={EUROPEAN JOURNAL OF NEUROLOGY},
volume={29},
number={},
pages={240-240},
document_type={Meeting Abstract},
}